Predicting Nonadherence to Medications for Acute Migraine
During a migraine attack, experiencing nausea with and without vomiting is associated with nonadherence to acute migraine medication guidelines.
During a migraine attack, experiencing nausea with and without vomiting is associated with nonadherence to acute migraine medication guidelines.
Researchers sought to determine whether combining memantine with a cholinesterase inhibitor produced early and consistent improvements in cognition for patients with moderate to severe Alzheimer disease.
Older men with type 2 diabetes who received metformin or newer hypoglycemic medication had less cognitive decline compared with those who received sulfonylureas.
Use of zonisamide showed long-term efficacy for Parkinsonism and dementia with Lewy bodies without deterioration of cognitive function.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments.
Long-term adjunctive treatment with amantadine may enable the levodopa regimen to be optimized in patients with Parkinson experiencing motor complications.
An expert subcommittee of the AAN has released an updated evidence-based clinical practice guideline on treating Tourette syndrome and other chronic tic disorders.
Serious infections related to treatment with rituximab in patients with multiple sclerosis are rare and successfully resolvable.
Droxidopa is associated with better treatment adherence than midodrine when medication cost is noninfluential.
Preliminary findings showed the decrease in botulinum toxin type A therapeutic effect over time warrants further study.